The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Phytoestrogens: End of a tale?
Open accessAbstract
Phytoestrogens are plant-derived hormone-like diphenolic compounds of dietary origin that are present at high levels in plasma of subjects living in areas with low atherosclerosis and cancer incidence. The term phytoestrogen is commonly applied to the soy isoflavones genistein, daidzein and glycitein. As outlined in a previous review article in this journal by Adlercreutz and Mazur 1, these compounds are weakly estrogenic and appear to influence the cardiovascular system, the production, metabolism and biological activity of sex-hormones, as well as malignant cell proliferation, differentiation and angiogenesis. Recently skepticism has developed concerning the true potential of phytoestrogens to beneficially modify these processes. A critical analysis of the early findings from supplementing the diet with soy protein has failed to confirm phytoestrogens as the responsible agent for beneficial cardiovascular effects, be it by way of lipid reduction, vasodilation or lipoprotein oxidation. Furthermore, contrasting data have been reported on the potential of phytoestrogens to prevent hormone-dependent cancers (e.g. breast and prostate) and to successfully treat post-menopausal complaints, an indication for which they are widely used. These potentially negative findings have led health authorities in several countries to suggest maximum daily intake levels for phytoestrogens. There is now growing interest in the use of soy products containing low levels of phytoestrogens and in research on other phytoestrogen free legumes such as lupin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β
Kuiper, G. G. J. M., Lemmen, J. G., Carlsson, B., Corton, J. C., Safe, S. H., van der Saag, P. T., van der Burg, B., & Gustafsson, J.-Å. (1998) · Endocrinology · doi:10.1210/endo.139.10.6216 · Cited by 4,203
Meta-Analysis of the Effects of Soy Protein Intake on Serum Lipids
Anderson, J. W., Johnstone, B. M., & Cook-Newell, M. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508033330502 · Cited by 2,048 · cited 1×
“The US FDA decision to allow promotion of soy protein for heart health was based on a meta-analysis indicating a significant total and low density lipoprotein (LDL) cholesterol reduction following an average soy protein intake of 47 g/day (23).”
BackgroundSetchell, K. D. R., Brown, N. M., & Lydeking-Olsen, E. (2002) · The Journal of Nutrition · doi:10.1093/jn/132.12.3577 · Cited by 1,209
Postmenopausal Hormone Replacement Therapy: Scientific Review
Nelson, H. D., Humphrey, L. L., Nygren, P., Teutsch, S. M., & Allan, J. D. (2002) · JAMA · doi:10.1001/jama.288.7.872 · Cited by 990 · cited 1×
“Hormone replacement therapy (HRT) can ameliorate the loss of estrogen in the menopause and provide clear benefit against osteoporosis (94), and a synthetic phytoestrogen, ipriflavone, was found to reduce bone loss in post-menopausal women (95).”
BackgroundVan Patten, C. L., Olivotto, I. A., Chambers, G. K., Gelmon, K. A., Hislop, T. G., Templeton, E., Wattie, A., & Prior, J. C. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.6.1449 · Cited by 265
Soya foods and breast cancer risk: A prospective study in Hiroshima and Nagasaki, Japan
Key, T. J., Sharp, G. B., Appleby, P. N., Beral, V, Goodman, M. T., Soda, M., & Mabuchi, K. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690837 · Cited by 262 · cited 1×
“There was no relationship between soy food consumption and BC risk in a case-control study in Chinese women (69) or in a more recent prospective study, in Japanese women (70).”
BackgroundMacGregor, C. A., Canney, P. A., Patterson, G., McDonald, R., & Paul, J. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.01.005 · Cited by 107
Sirtori, C. R., Pazzucconi, F., Colombo, L., Battistin, P., Bondioli, A., & Descheemaeker, K. (1999) · British Journal Of Nutrition · doi:10.1017/s0007114599001233 · Cited by 46
Self-citation
Cited by
The pros and cons of phytoestrogens
Patisaul, H. B., & Jefferson, W. (2010) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2010.03.003 · Cited by 746
“Numerous epidemiological and clinical studies have now evaluated the relationship between phytoestrogen consumption and human disease outcomes, but the results have not yielded a clear picture as to whether or not these compounds have therapeutic potential [36,261].”
Bonefeld-Jørgensen, E. C., Long, M., Hofmeister, M. V., & Vinggaard, A. M. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.9368 · Cited by 502
Role of Phytochemicals in Cancer Chemoprevention: Insights
George, B. P., Chandran, R., & Abrahamse, H. (2021) · Antioxidants · doi:10.3390/antiox10091455 · Cited by 295
Gene expression profiling gets to the root of human hair follicle stem cells
Cotsarelis, G. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27490 · Cited by 105
Metadata
- Authors
- Sirtori, C. R., Arnoldi, A., & Johnson, S. K.
- Venue
- Annals of Medicine
- Publisher
- Informa UK Limited
- Published
- 2005-01
- Volume
- 37
- Issue
- 6
- Pages
- 423-438
- ISSN
- 0785-3890 (ISSN-L)
- 1365-2060
- OpenAlex
- W2060791667
- Cited by
- 173
- References
- 8
- FWCI
- 8.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.